Please ensure Javascript is enabled for purposes of website accessibility

Retailers Push The Dow Higher Again

By Jeremy Bowman - Updated Nov 17, 2016 at 4:25PM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Dow posted gains for the fourth day in a row on a mix of good news.

The Dow Jones Industrial Average (^DJI 0.03%) took one step closer to a perfect week today, gaining 63 points or 0.4%, to finish at 14,865, as a number of strong retail reports helped boost investor confidence. Ross Stores, Rite Aid, and Zumiez all jumped 6% or more, pulling up the broader sector and the market as a whole, as investors seemed to be reassured that consumers were still spending despite the payroll tax increase, and concerns about sequestration. Tomorrow's official retail sales report could help confirm today's news.

A lower-than-expected initial unemployment claims report also helped push stocks higher. New jobless claims dropped to 346,000, from 388,000 the week before, perhaps proving that last week's spike was just a fluke.

Tech stocks, however, were down sharply, as a report from International Data Corp. showed that PC shipments globally dropped 14% in the first quarter, the worst quarterly drop since the research firm started tracking sales in 1994. The tech-heavy Nasdaq was the poorest performer of the three major indexes, moving up just 0.1%.

Not surprisingly, Hewlett-Packard (HPQ -3.02%) shares took the news, particularly hard, falling 6.5%. The report also showed that rival Lenovo gained market share, while HP and Dell dropped. Lenovo finished the quarter with a 14.7% share, just slightly behind HP, with 14.8%, according to Gartner. Microsoft and Intel were also off sharply as well, falling 4.4% and 2% respectively.

Pfizer (PFE 3.59%) was the biggest gainer on the Dow, a strong gainer for the second day in row, moving up 2.4% after the FDA called its new breast-cancer drug a "breakthrough" innovation. The FDA designation should help speed up the approval process for palbociclib, and comes at a time when Pfizer has been dealing with a patent cliff from the recent expiration of Lipitor.

 

 

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

Dow Jones Industrial Average (Price Return) Stock Quote
Dow Jones Industrial Average (Price Return)
^DJI
$31,261.90 (0.03%) $8.77
HP Inc. Stock Quote
HP Inc.
HPQ
$34.65 (-3.02%) $-1.08
Pfizer Inc. Stock Quote
Pfizer Inc.
PFE
$52.47 (3.59%) $1.82

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning service.

Stock Advisor Returns
330%
 
S&P 500 Returns
115%

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 05/22/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.